Previous 10 | Next 10 |
So far, 2022 has been an awful year for the stock market. We've seen really bad inflation, and many investors think a recession is imminent. Nonetheless, some companies are reporting surprisingly strong numbers. Here are three healthcare stocks that missed their guidance -- in the right...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Even the best telehealth stocks have been smashed hard this year for two reasons. First, they’re typically high-beta assets, meaning they’ve experienced excess sensitivity to 2022’s bear market. And se...
The equity correction has brought stock prices and sentiment closer to levels where risk/reward becomes asymmetric to the upside. We believe a pickup in merger & acquisition activity would be an early signal that undervalued assets are becoming monetized. Steadily growing, highly ...
Steadily growing, highly free-cash-flow-generative companies enabled the Strategy to outperform through a sharp market pullback. Positioning moves during the quarter, which included additions in health care and materials as well as reductions in consumer discretionary and technology, ...
Exposure to disruptors in areas of the market that have derated after a surge in demand during the pandemic, namely consumer technology and e-commerce, weighed on performance in a difficult quarter for higher growth stocks. We were active during the quarter, tactically pivoting the po...
The market experienced a widespread rout across every market sector as companies faced higher inflation, interest rate hikes and growing recession concerns. We have a high degree of confidence our existing portfolio holdings will generate superior long-term returns over a full market ...
Some investors are looking at technology stocks with a skeptical eye right now. With inflation still at a nearly 40-year high and the Federal Reserve focused on bringing it down by hiking the federal funds rate, investors have been less keen to buy high-growth tech stocks. But the recen...
Steadily growing, highly free-cash-flow-generative and more moderately valued companies enabled the Strategy to outperform through a sharp market pullback. Heightened volatility provided opportunities to purchase shares in growth companies on our watchlist, as well as add to existing ...
Doximity to Release Fiscal 2023 First Quarter Results on August 4, 2022 PR Newswire SAN FRANCISCO , July 14, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced it will report...
Doximity (NYSE: DOCS) was a hot stock when it went public in 2021. Its shares would rise to a value of more than $100 in September of that year before ultimately falling heavily. Today, at around $40 per share, it's nowhere near those highs. However, its valuation was already too ri...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...